Praful Ravi, Mb Bchir, Mrcp

This early-stage study tests two oral drugs, darolutamide and abemaciclib, plus standard hormone therapy in men with high-risk prostate cancer that has spread or may come back. The first part finds the safest dose; the second checks if the combo can shrink tumors before surgery. …